MOBICON GROUP (01213) issues profit warning, with the anticipated mid-term loss attributable to shareholders expected to increase by about HK$4-6 million compared to the same period last year.
Wan Baogang Group (01213) announced that the group is expected to obtain shareholders... for the six months ending on September 30, 2024.
MOBICON GROUP (01213) announced that the Group is expected to incur a loss attributable to shareholders of approximately HK$40 to HK$60 million for the six months ending on September 30, 2024. This is an increase from the loss of approximately HK$23 million incurred for the six months ending on September 30, 2023.
The announcement stated that the significant increase in the loss was mainly due to one of the Group's subsidiaries in South Africa experiencing a decrease in revenue due to a drop in demand for electrical components during the reporting period, which had an adverse impact on the Group's financial performance.
Related Articles

HK Stock Market Move | WESTCHINACEMENT(02233) surged more than 4% in the final trading session. The company is expected to gradually establish its leading position in the cement industry in the African region.

A-share market closing review | Good news boosts A-shares to a strong start! The Shanghai Composite Index returned to 4000 points, achieving a rare 12-day winning streak, with the Sci-Tech Innovation Board rising over 4%.

Citigroup: Upgraded ZOOMLION (01157) rating to "buy" with target price raised to HK$10.2.
HK Stock Market Move | WESTCHINACEMENT(02233) surged more than 4% in the final trading session. The company is expected to gradually establish its leading position in the cement industry in the African region.

A-share market closing review | Good news boosts A-shares to a strong start! The Shanghai Composite Index returned to 4000 points, achieving a rare 12-day winning streak, with the Sci-Tech Innovation Board rising over 4%.

Citigroup: Upgraded ZOOMLION (01157) rating to "buy" with target price raised to HK$10.2.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


